Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

8.060 -0.300 (-3.59%)

Delayed Quote Updated: 1:43 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

12 Health Care Stocks Moving In Monday's Intraday Session ↗

September 30, 2024

Via Benzinga

Crude Oil Moves Higher; Prime Medicine Shares Spike Higher ↗

September 30, 2024

Via Benzinga

Prothena Announces Leadership Team Updates

September 27, 2024

From Prothena Corporation plc

Via Business Wire

Prothena to Participate in Upcoming Healthcare Conferences

August 29, 2024

From Prothena Corporation plc

Via Business Wire

Demystifying Prothena Corp: Insights From 8 Analyst Reviews ↗

March 13, 2024

Via Benzinga

Decoding 6 Analyst Evaluations For Prothena Corp ↗

February 16, 2024

Via Benzinga

PRTA Stock Earnings: Prothena Corp Beats EPS, Beats Revenue for Q2 2024 ↗

August 08, 2024

PRTA stock results show that Prothena Corp beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Prothena Reports Second Quarter 2024 Financial Results and Business Highlights

August 08, 2024

From Prothena Corporation plc

Via Business Wire

Prothena to Report Second Quarter 2024 Financial Results on August 8

August 01, 2024

From Prothena Corporation plc

Via Business Wire

Eli Lilly Drags Alzheimer's Stocks Prothena, Eisai Lower Despite FDA Win ↗

June 11, 2024

An FDA panel unanimously backed Eli Lilly's Alzheimer's drug, but shares of Lilly and its rivals fell Tuesday.

Via Investor's Business Daily

Prothena Corp: Q4 Earnings Insights ↗

February 15, 2024

Via Benzinga

Earnings Scheduled For February 15, 2024 ↗

February 15, 2024

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.

Via Benzinga

Earnings Outlook For Prothena Corp ↗

February 14, 2024

Via Benzinga

Navigating 5 Analyst Ratings For Prothena Corp ↗

January 25, 2024

Via Benzinga

Prothena Announces Bristol Myers Squibb Opt-in for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration

May 28, 2024

From Prothena Corporation plc

Via Business Wire

PRTA Stock Earnings: Prothena Corp Misses EPS, Misses Revenue for Q1 2024 ↗

May 08, 2024

PRTA stock results show that Prothena Corp missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

Prothena Reports First Quarter 2024 Financial Results and Business Highlights

May 08, 2024

From Prothena Corporation plc

Via Business Wire

Prothena to Report First Quarter 2024 Financial Results on May 8

May 01, 2024

From Prothena Corporation plc

Via Business Wire

$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today ↗

January 22, 2024

Via Benzinga

Demystifying Prothena Corp: Insights From 5 Analyst Reviews ↗

January 09, 2024

Via Benzinga

Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma

April 15, 2024

From Prothena Corporation plc

Via Business Wire

Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback ↗

March 28, 2024

The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting.

Via Investor's Business Daily

Prothena to Participate in Upcoming Healthcare Conferences

March 05, 2024

From Prothena Corporation plc

Via Business Wire

Prothena Appoints David Ford to Newly Created Chief People Officer Position

March 04, 2024

From Prothena Corporation plc

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

February 29, 2024

Via Benzinga

Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate

February 21, 2024

From Prothena Corporation plc

Via Business Wire

Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights

February 15, 2024

From Prothena Corporation plc

Via Business Wire

Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024

February 08, 2024

From Prothena Corporation plc

Via Business Wire

Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 30, 2024

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter sales results and issued FY24 sales

Via Benzinga

Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 09, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.